Fingerprint
Dive into the research topics of 'Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study
J. Menczer*, G. Ben-Baruch, S. Rizel, H. Brenner
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations